We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS TO EXPEDITE REVIEW OF COMBINATION AIDS DRUGS, ALLOW GENERICS
HHS TO EXPEDITE REVIEW OF COMBINATION AIDS DRUGS, ALLOW GENERICS
June 1, 2004
In a policy shift that could allow generic firms to sell AIDS drugs that are still under patent, U.S. health officials are easing the way for brand and generic drugmakers to submit applications for fixed-dose combination (FDC) products to treat HIV in poor countries.